Sorafenib Videos
Robert G. Gish, MD - Evidence-Based Treatment of Intermediate- to Advanced-Stage Hepatocellular ...
In this activity, an expert in liver diseases discusses clinical issues and the latest evidence in the treatment of hepatocellular ... tags: BCLC bevacizumab Child_Pugh_Turcotte ECOG HCC liver_cancer Science,_Medicine
10/13/08 from PeerView CME/CE Audio Podcast - Oncology
Robert J. Motzer, MD - mTOR Inhibitors in RCC and Other Solid Tumors: Preventing Deleterious ...
In this activity, an expert in oncology discusses the current and emerging role of mTOR inhibitors in renal cell carcinoma and other solid ... tags: bevacizumab deforolimus everolimus mTOR RCC renal_cell Science,_Medicine
12/19/08 from PeerView CME/CE Audio Podcast - Oncology
Smoking Increases Colon Cancer Risk, Sorafenib Increases Survival Among Liver Cancer Patients, ...
(December 17, 2008 - Insidermedicine) From Italy - According to research in the Journal of the American Medical Association, smoking ... tags: Among Cancer Colon Health Increases Infants Liver
12/17/08 from Insidermedicine Daily News (Video)
Vincent A. Miller, MD - Unique Toxicity Profile of Antiangiogenic Agents Must Be Considered When ...
In this educational program, an expert describes the unique safety profile of the antiangiogenic agents in lung cancer, and discusses how ... tags: antiangiogenesis NSCLC cytotoxics bevacizumab febrile_neutropenia sunitinib sorafenib
06/12/08 from PeerView CME/CE Audio Podcast - Oncology
Robert J. Motzer, MD - Integrating Emerging Therapies to Improve Outcomes in Renal Cell Carcinoma
In this CME program, an expert in the treatment of renal cell carcinoma discusses advances in the use of targeted therapies in the ... tags: renal_cell_carcinoma renal_cell_cancer RCC metastatic_RCC advanced_RCC targeted_therapies tyrosine_kinase_inhibitors
01/21/08 from PeerView CME/CE Audio Podcast - Oncology
Ezra Cohen, MD - Integrating Targeted Agents Into Treatment of NSCLC : A Case-Based Approach
In this CME activity, an expert discusses treatment of advanced NSCLC, with a main focus on optimal integration of targeted agents into ... tags: lung_cancer NSCLC targeted_therapy biologics VEGF EGFR erlotinib
10/26/07 from PeerView CME/CE Audio Podcast - Oncology
Roy S. Herbst - Clinical Updates on Targeted Therapy for Lung Cancer
In this activity, experts in the treatment of lung cancer present the most current data on molecularly targeted agents in the treatment of ... tags: asco Avastin bevacizumab biologics EGFR erlotinib gefitinib
09/25/07 from PeerView CME/CE Audio Podcast - Oncology
Bernard Escudier, MD - Advances in Targeted Therapy for Renal Cell Carcinoma
In this CME activity, experts in the treatment of advanced renal cell carcinoma discuss recent data on the efficacy and safety of current ... tags: advanced RCC advanced_RCC bevacizumab erlotinib IFN-α IL-2 integrated
08/22/07 from PeerView CME/CE Audio Podcast - Oncology
Al B. Benson III, MD - State of the Science in Hepatocellular Carcinoma: Focus on Targeted Therapy
In this CME activity, experts in the treatment of hepatocellular carcinoma (HCC) discuss recent data on the efficacy and safety of emerging ... tags: hepatocellular carcinoma hcc targeted agents Biologic agents staging systems Hepatitis B hepatitis
08/24/07 from PeerView CME/CE Audio Podcast - Oncology
Alan B. Sandler, MD - Current and Emerging Role of Antiangiogenic Therapy in Lung Cancer
This CME activity reviews current perspectives on antiangiogenic therapy in lung cancer. Data from clinical trials evaluating ... tags: NSCLC targeted therapy biologics VEGF antiangiogenic ECOG 4599 angiogenesis inhibition
04/24/07 from PeerView CME/CE Audio Podcast - Oncology